Walker VJ et al. |
Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:27000802
|
Oz M et al. |
Additive effects of endogenous cannabinoid anandamide and ethanol on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15687372
|
Kangas BD et al. |
Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:26826191
|
Vanheel B and Van de Voorde J |
Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11160613
|
Aceto MD et al. |
Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808686
|
Fulton D and Quilley J |
Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9732371
|
Welch SP et al. |
Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9732392
|
Appendino G et al. |
Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential. |
2005 |
J. Pharmacol. Exp. Ther. |
pmid:15356216
|
Anikwue R et al. |
Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12235269
|
Rockwell CE and Kaminski NE |
A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15284281
|
Solinas M et al. |
Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17351107
|
Fride E et al. |
Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7853184
|
Miller LL et al. |
Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22514333
|
Caprioli A et al. |
The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22514334
|
Adams IB et al. |
Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7791088
|
Welch SP et al. |
Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7791096
|
Ritter JK et al. |
Production and actions of the anandamide metabolite prostamide E2 in the renal medulla. |
2012 |
J. Pharmacol. Exp. Ther. |
pmid:22685343
|
McAllister SD et al. |
Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10525080
|
Glaser ST and Kaczocha M |
Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain. |
2010 |
J. Pharmacol. Exp. Ther. |
pmid:20702753
|
Orliac ML et al. |
Potentiation of anandamide effects in mesenteric beds isolated from endotoxemic rats. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12490589
|
Wang Y et al. |
Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17308041
|
Varvel SA et al. |
Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16352706
|
Rösch S et al. |
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16330497
|
Snider NT et al. |
Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17272674
|
Solinas M et al. |
The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. |
2007 |
J. Pharmacol. Exp. Ther. |
pmid:17210800
|
Lake KD et al. |
Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9190833
|
Griffin G et al. |
Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10688601
|
Rakhshan F et al. |
Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10688610
|
Glaser ST et al. |
Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16278311
|
Muthian S et al. |
Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10734181
|
Scherma M et al. |
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:18725543
|
Adams IB et al. |
Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9495885
|
Fowler CJ et al. |
Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship. |
1997 |
J. Pharmacol. Exp. Ther. |
pmid:9353392
|
Chiba T et al. |
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells. |
2011 |
J. Pharm. Pharmacol. |
pmid:21492165
|
Hayase T et al. |
Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. |
2001 |
J. Pharm. Pharmacol. |
pmid:11732755
|
Di Marzo M et al. |
Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics. |
2006 |
J. Pept. Sci. |
pmid:16534762
|
Gómez R et al. |
Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes. |
2014 |
J. Orthop. Res. |
pmid:24902823
|
Hutchins-Wiese HL et al. |
Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle. |
2012 |
J. Nutr. Biochem. |
pmid:22051448
|
Battista N et al. |
Abnormal anandamide metabolism in celiac disease. |
2012 |
J. Nutr. Biochem. |
pmid:22209002
|
Hutchins HL et al. |
Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. |
2011 |
J. Nutr. Biochem. |
pmid:20951563
|
Mennella I et al. |
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans. |
2015 |
J. Nutr. |
pmid:26180248
|
Batetta B et al. |
Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. |
2009 |
J. Nutr. |
pmid:19549757
|
Thomas EA et al. |
Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. |
1997 |
J. Neurosci. Res. |
pmid:9452020
|
Bari M et al. |
Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. |
2005 |
J. Neurosci. Res. |
pmid:15920744
|
Molina-Holgado F et al. |
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. |
2002 |
J. Neurosci. Res. |
pmid:11891798
|
Arias-Carrión O et al. |
Biochemical modulation of the sleep-wake cycle: endogenous sleep-inducing factors. |
2011 |
J. Neurosci. Res. |
pmid:21557294
|
Bajo M et al. |
Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands. |
2009 |
J. Neurosci. Res. |
pmid:18816788
|
Shinjyo N et al. |
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system. |
2013 |
J. Neurosci. Res. |
pmid:23633391
|
Bannerman P et al. |
Early migratory rat neural crest cells express functional gap junctions: evidence that neural crest cell survival requires gap junction function. |
2000 |
J. Neurosci. Res. |
pmid:10972957
|
Ahern GP et al. |
Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. |
2005 |
J. Neurosci. |
pmid:15917451
|
Tabatadze N et al. |
Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus. |
2015 |
J. Neurosci. |
pmid:26269634
|
Gómez R et al. |
A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. |
2002 |
J. Neurosci. |
pmid:12417686
|
Gray JM et al. |
Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. |
2015 |
J. Neurosci. |
pmid:25740517
|
Wang ZJ et al. |
Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb. |
2012 |
J. Neurosci. |
pmid:22723687
|
Xiong W et al. |
A common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptors. |
2012 |
J. Neurosci. |
pmid:22496565
|
Franklin A et al. |
Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. |
2003 |
J. Neurosci. |
pmid:12944505
|
Shen Y et al. |
A transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells. |
2009 |
J. Neurosci. |
pmid:19439586
|
Derkinderen P et al. |
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. |
2003 |
J. Neurosci. |
pmid:12657697
|
Clement AB et al. |
Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. |
2003 |
J. Neurosci. |
pmid:12736361
|
Marinelli S et al. |
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. |
2003 |
J. Neurosci. |
pmid:12716921
|
Massa F et al. |
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. |
2010 |
J. Neurosci. |
pmid:20445053
|
Tognetto M et al. |
Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. |
2001 |
J. Neurosci. |
pmid:11160380
|
Cadas H et al. |
Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. |
1996 |
J. Neurosci. |
pmid:8656287
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Beltramo M et al. |
Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. |
2000 |
J. Neurosci. |
pmid:10777802
|
Lerner TN et al. |
Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists. |
2010 |
J. Neurosci. |
pmid:20147543
|
Garami A et al. |
Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis. |
2011 |
J. Neurosci. |
pmid:21289181
|
Justinova Z et al. |
The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. |
2005 |
J. Neurosci. |
pmid:15944392
|
Subbanna S et al. |
Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits. |
2013 |
J. Neurosci. |
pmid:23575834
|
Dinis P et al. |
Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. |
2004 |
J. Neurosci. |
pmid:15601931
|
Akerman S et al. |
Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine. |
2013 |
J. Neurosci. |
pmid:24027286
|
Ade KK and Lovinger DM |
Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dorsolateral striatum. |
2007 |
J. Neurosci. |
pmid:17329438
|
Khlaifia A et al. |
Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-Hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers. |
2013 |
J. Neurosci. |
pmid:23904599
|
Kim D and Thayer SA |
Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. |
2001 |
J. Neurosci. |
pmid:11319244
|
Khasabova IA et al. |
A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. |
2008 |
J. Neurosci. |
pmid:18971457
|
Veldhuis WB et al. |
Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. |
2003 |
J. Neurosci. |
pmid:12764100
|
Cadas H et al. |
Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. |
1997 |
J. Neurosci. |
pmid:9006968
|
Khasabova IA et al. |
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. |
2012 |
J. Neurosci. |
pmid:22593077
|
Qin N et al. |
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. |
2008 |
J. Neurosci. |
pmid:18550765
|
Chemin J et al. |
Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. |
2002 |
J. Neurosci. |
pmid:12177183
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|
Kim SR et al. |
Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. |
2005 |
J. Neurosci. |
pmid:15659603
|
Ali AB |
Presynaptic Inhibition of GABAA receptor-mediated unitary IPSPs by cannabinoid receptors at synapses between CCK-positive interneurons in rat hippocampus. |
2007 |
J. Neurophysiol. |
pmid:17567776
|
Fischbach T et al. |
Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats. |
2007 |
J. Neurophysiol. |
pmid:17581853
|
Uhelski ML et al. |
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy. |
2015 |
J. Neurophysiol. |
pmid:25505113
|
Fan P |
Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. |
1995 |
J. Neurophysiol. |
pmid:7760148
|
Fisyunov A et al. |
Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons. |
2006 |
J. Neurophysiol. |
pmid:16738209
|
De-May CL and Ali AB |
Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex. |
2013 |
J. Neurophysiol. |
pmid:23054605
|
Morisset V and Urban L |
Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. |
2001 |
J. Neurophysiol. |
pmid:11431486
|
Twitchell W et al. |
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. |
1997 |
J. Neurophysiol. |
pmid:9242259
|
Contassot E et al. |
Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. |
2004 |
J. Neuropathol. Exp. Neurol. |
pmid:15453094
|
Jean-Gilles L et al. |
Plasma endocannabinoid levels in multiple sclerosis. |
2009 |
J. Neurol. Sci. |
pmid:19695579
|
Di Filippo M et al. |
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. |
2008 |
J. Neurol. Neurosurg. Psychiatr. |
pmid:18535023
|
Stefano GB |
Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. |
1998 |
J. Neuroimmunol. |
pmid:9610675
|
Eisenstein TK et al. |
Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. |
2007 |
J. Neuroimmunol. |
pmid:17640739
|
Schwarz H et al. |
Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. |
1994 |
J. Neuroimmunol. |
pmid:7962480
|
De Laurentiis A et al. |
The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide. |
2010 |
J. Neuroimmunol. |
pmid:20207018
|
Hollis JH et al. |
The endocannabinoid arachidonylethanolamide attenuates aspects of lipopolysaccharide-induced changes in energy intake, energy expenditure and hypothalamic Fos expression. |
2011 |
J. Neuroimmunol. |
pmid:21262543
|
Malfitano AM et al. |
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. |
2006 |
J. Neuroimmunol. |
pmid:16239036
|
Bisogno T |
Endogenous cannabinoids: structure and metabolism. |
2008 |
J. Neuroendocrinol. |
pmid:18426492
|